First fixed drug eruption due to teicoplanin with a peri-oral distribution.
Duong
T
T
Hamel
D
D
Benlahrech
S
S
Le Quan Sang
K H
KH
Sauvé-Martin
H
H
De Prost
Y
Y
Roujeau
J C
JC
Hadj-Rabia
S
S
D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D003875:Drug Eruptions / Q000175:diagnosis* / Q000473:pathology; D005260:Female; D006801:Humans; D009055:Mouth / Q000473:pathology; D013203:Staphylococcal Infections / Q000188:drug therapy; D013211:Staphylococcus aureus; D017334:Teicoplanin / Q000009:adverse effects* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D017334:Teicoplanin